NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spirovant Sciences

Spirovant Sciences

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://spirovant.com/

Last Round

Grant

Jan 23, 2019

Total Funding Raised

$4.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Spirovant Sciences is a biotechnology company that develops gene therapies for cystic fibrosis and other respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

CF treatmentcystic fibrosis treatmentgene therapyAAV gene therapymutation-agnostic therapyCFTR gene therapyadeno-associated virusAAVrespiratory disease therapyinhaled gene therapyaerosol-delivered therapyclinical-stage companyOrphan Drug DesignationRare Pediatric Disease Designationgene delivery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spirovant Sciences Comparables

Compare Spirovant Sciences with similar companies based on industry and business-model similarity.

Spirovant Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ReCode Therapeutics
87%
4DMT
82%
Krystal Biotech, Inc.
81%

Spirovant Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 23, 2019

Key People

Founding team and executive leadership

Eric Pastor

Chief Technology Officer

Executive Team

David Whitwell

Chief Financial Officer

Executive Team

Spirovant Sciences Investors

Notable investors and investment history

Spirovant Sciences investors
InvestorRounds
Emily's EntourageSeed
Militia Hill VenturesSeed
Cystic Fibrosis FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors increased 63% MoM.

  • Jan 20, 2026

    Monthly visitors increased 165% MoM.

Spirovant Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spirovant Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spirovant Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range16
Year Founded2016
Last FundingJan 23, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.